Search results
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
Washington Post· 6 hours agoIn making this case, other potential applicants described the approach by Lykos, and its nonprofit...
Virtual reality could unlock better treatment for psychosis — a use case that's gaining traction...
Business Insider via Yahoo News· 1 day agoFreeman, a psychology professor at Oxford University, published the results of a landmark clinical ...
Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Salon via Yahoo News· 1 day agoPsilocybin is one of several psychedelic drugs currently being explored as treatments for a variety...
FDA advisors express skepticism as they debate MDMA therapy for PTSD
WUSF 89.7· 4 days agoThe psychedelic drug MDMA, which has been studied as a possible mental health treatment, may finally...
Psychedelics Have a Placebo Problem
The Atlantic· 5 days agoThe fate of the treatment—MDMA-assisted therapy for post-traumatic stress disorder—will turn on how the FDA interprets data from two clinical trials...
Oklahoma man who stabbed father at Braum's could get day passes; AG, county DA fight back
The Oklahoman· 5 days agoA treatment team at a state mental hospital is again recommending day passes for Christian Costello,...
Psychoactive drugs are having a moment: The FDA will soon weigh in
Medical Xpress· 5 days agoThen she answered an ad for a clinical trial for MDMA-assisted therapy to treat post-traumatic...
FDA advisers consider MDMA therapy to treat PTSD
KITV Honolulu· 4 days agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next
BioPharma Dive via Yahoo Finance· 1 day agoA vote against MDMA-assisted therapy set back a high-profile treatment. Proponents argue the panel...
MDMA-maker failed its FDA hearing — and its PTSD patients
The Eagle-Tribune· 3 hours agoAdministration’s expert advisers sent a strong message that Lykos Therapeutics Inc.’s MDMA-assisted...